Gene Therapy Supports Long-Term Reconstitution of Patient Hematopoietic Stem Cells in Deficiency of Adenosine Deaminase 2

Researchers developed a lentiviral vector to restore adenosine deaminase 2 expression in patient hematopoietic stem and progenitor cells and evaluated its safety and efficacy in preclinical models.